Boston Globe Examines U.S. Global Health Strategy
The Boston Globe examines the U.S. strategy towards global health aid.
Filling the need for trusted information on national health issues
Filling the need for trusted information on national health issues
Total Results: 1,233
Sorting by Relevance | Sort by Date
June 15, 2009 News Summary
The Boston Globe examines the U.S. strategy towards global health aid.
June 19, 2009 News Summary
Lancet Commentary Examines How PEPFAR Failing To Reach IDUs Although PEPFAR has helped to provide “antiretroviral therapy to 2.1 million people with HIV, almost all of whom live in sub-Saharan Africa, and has spent more than US$18 billion on the continent” it has failed to reach “thousands of injecting drug…
June 24, 2009 News Summary
On the News Hour Insider Forum, Ray Suarez interviews global health experts Michele Moloney-Kitts, assistant U.S. global AIDS coordinator, and Christine Lubinski, head of the Center for Global Health Policy and Advocacy about President Obama’s $63 billion global health initiative.
June 26, 2009 News Summary
Kenya’s Medical Services Permanent Secretary James Ole Kiyiapi announced Thursday that the government is in negotiations with PEPFAR for support in building additional blood transfusion centers in the country, Capital News reports.
July 28, 2009 News Summary
The U.S., WHO and representatives from 13 African countries on Monday launched an effort to boost the standards for quality medical labs on the continent, VOA News reports.
September 4, 2009 News Summary
Local Drug Production Doesn’t Increase Access, Undermines Quality The international community focuses on lowering drug prices as a means of improving access and “today its idea is local pharmaceutical production … But while the German Government and other countries’ aid agencies are helping fund small firms in Africa, they have…
October 5, 2009 News Summary
The BBC examines the balance between funding for HIV/AIDS and for the broader health system and other diseases in Uganda.
October 16, 2009 News Summary
HHS recently announced the FDA’s 100th approval of an antiretroviral drug for PEPFAR, PharmTech.com reports. Seventy-one of the more than 100 drugs reviewed by FDA for PEPFAR were generic products. HHS Secretary Kathleen Sebelius said in a statement, “This milestone exemplifies the dedication, caring, and hard work of all who strive to better the lives of those infected with or affected by HIV/AIDS” (10/15).
October 14, 2009 News Summary
Rights Advocacy Not The Best Approach For Global Health “[T]he global campaign to equalise access to healthcare has had a surprising result: it has made global healthcare more unequal,” William Easterly, a professor of economics at New York University and co-director of its Development Research Institute, writes in a Financial Times…
April 25, 2013 News Summary
On Tuesday, April 30, from 2:00-3:30 p.m., the Kaiser Family Foundation and the Center for Strategic and International Studies (CSIS) Global Health Policy Center will host a panel discussion, titled “The Policy Implications of the Institute of Medicine’s Evaluation of PEPFAR,” at the CSIS conference center in Washington, D.C. Moderated…